Contact Us

Newsroom

News & Announcements

Milestones, partnerships and recognition from Sudair Pharma's work to strengthen pharmaceutical manufacturing in the Kingdom.

Local Content & Government Partnerships
30 October 2025

Sudair Pharma Signs Strategic Agreements at GHE25 to Strengthen National Pharmaceutical Supply and Local Manufacturing

Sudair Pharma signed two major agreements during the Global Health Exhibition 2025: a cooperation agreement with NUPCO to enhance the national pharmaceutical supply chain, and a localization agreement with the Local Content & Government Procurement Authority to manufacture Bilotinib locally. These agreements reinforce Sudair Pharma’s commitment to national self-sufficiency and Vision 2030 goals in pharmaceutical manufacturing.

Exhibition
29 October 2025

Sudair Pharma Welcomes the Minister of Health and Distinguished Delegation at the Global Health Exhibition 2025

Sudair Pharma was honored to welcome His Excellency the Minister of Health, Fahad Al-Jalajel, during its participation in the Global Health Exhibition 2025. The visit highlighted the Kingdom’s commitment to strengthening national pharmaceutical manufacturing and advancing a sustainable healthcare system. Several senior officials and leaders also visited the booth, underscoring Sudair Pharma’s growing impact in shaping the future of Saudi healthcare.

Media & Press Coverage
21 October 2025

Sudair Pharma CEO Named Among Forbes Middle East Top Healthcare Leaders

Sudair Pharma announced that its Chief Executive Officer has been selected by Forbes Middle East as one of the Top Healthcare Leaders, recognizing his contribution to advancing Saudi pharmaceutical manufacturing and strengthening national healthcare capabilities.

Media & Press Coverage
8 October 2025

Sudair Pharma Welcomes the Ambassador of Ukraine to the Kingdom

Sudair Pharma welcomed His Excellency Anatolii Petrenko, Ambassador of Ukraine to the Kingdom of Saudi Arabia, accompanied by senior officials from MODON. The delegation visited Sudair Pharma’s manufacturing facility to learn about the company’s key localization projects in the pharmaceutical sector.

Exhibition
22 December 2024

Sudair Pharma Achieves “Saudi Made” Golden Tier Classification

Sudair Pharma has been awarded the prestigious Saudi Made Golden Tier classification, recognizing the company’s exceptional contribution to national localization efforts, investment in Saudi talent, and utilization of locally sourced materials in pharmaceutical manufacturing.

Exhibition
22 November 2024

Sudair Pharma Showcases Major Local Content Achievements at the Local Content Forum 2024

Sudair Pharma participated prominently in the Local Content Forum 2024, announcing the launch of its “Ghrs Program” for local content development, showcasing strategic achievements, and taking part in key panel discussions, workshops, and exhibitions. The company reaffirmed its commitment to strengthening national pharmaceutical security and advancing local innovation in alignment with Saudi Vision 2030.

Exhibition
30 January 2024

Saudi Minister of Health Visits Sudair Pharma to Review Advanced Pharmaceutical Facilities and Strengthen National Drug Security

Sudair Pharma welcomed His Excellency the Minister of Health for an official visit to review the company’s advanced manufacturing facilities and pharmaceutical technologies. The visit also included a symbolic palm-tree planting ceremony and highlighted Sudair Pharma’s pivotal role in strengthening national drug security and supporting Vision 2030 objectives.

Media & Press Coverage
27 December 2023

Sudair Pharma CEO Featured on Saudi TV’s “AlMashroa” Program

Sudair Pharma CEO, Dr. Yasser Alobaidaa, appeared on Saudi TV’s “AlMashroa” program to discuss the company’s strategic direction, national ambitions, and the role of local pharmaceutical manufacturing in supporting Saudi Arabia’s healthcare future.